Navigation Links
Echo Therapeutics Announces 2010 Financial Results
Date:3/21/2011

eutics and Ferndale Pharma Group successfully completed a clinical trial that determined the efficacy of Prelude in enhancing the onset of activity of 4% lidocaine cream.
  • In November 2010, Echo Therapeutics' licensing partner, Ferndale Pharma Group, submitted a 510(k) premarket notification to the United States Food and Drug Administration (FDA) for the Prelude SkinPrep System and 4% lidocaine cream.

  • "We made very tangible progress during 2010 on all of our key programs and we achieved some very important milestones, including the successful submission of a 510(k) premarket notification to the United States Food and Drug Administration (FDA) for our Prelude device to enhance the delivery of 4% topical lidocaine cream with our partner Ferndale Pharma Group," commented Patrick T. Mooney, M.D., Chairman and Chief Executive Officer of Echo Therapeutics. "Additionally, we raised significant capital to fund our operations aggressively through final development."

    Fiscal Year 2010 Financial ResultsFor fiscal year 2010, the Company was principally involved with the product development and clinical studies of its Prelude SkinPrep System. Through licenses with Ferndale and Handok, the company recognized license fee revenue amortization of approximately $226,000 for fiscal 2010.  During fiscal year 2010, the Company received approximately $245,000 in other income related to a federal grant under the Qualified Therapeutic Discovery Projects Grants Program.  The Company's operating expenses for fiscal year 2010 of $5.3 million decreased by approximately $0.5 million compared with fiscal year 2009.  The net loss for fiscal 2010 was $4.1 million, or ($0.15) per share, compared to a net loss of $11.0 million, or ($0.61) per share for fiscal 2009.  The Company reported a cash balance of approximately $5.1 million as of March 18, 2011 as a result of equity financings completed during the period January 2011 to March 18, 2011.2011 Ou
    '/>"/>

    SOURCE Echo Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
    3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
    6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
    7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
    8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
    9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
    10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
    11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... -- Does your doctor know what you,re smoking?  Chances are, ... to the over 112,000 currently registered patients under ... other roughly 20,300+ active physicians listed with the Colorado Dept ... even though a poll in February 2014 showed 51% of ... it. "With marijuana legalization underway, every doctor ...
    (Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
    (Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
    Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
    (Date:8/30/2014)... Acne is a common problem millions of American cope ... than a daily nuisance, for some, it can have a crippling ... even lead to dramatic mood swings and depression. , Those ... up their skin. In some cases, that can make the problem ... error, those on a quest for clearer skin can now view ...
    (Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... and other incretin mimetic claims continue to move forward ... a statement issued by AstraZeneca PLC on July 31, ... have been named in 409 product liability claims that ... cancer. Court documents indicate that many of these claims ...
    (Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, ... on for broken bones or other orthopedic trauma shops around ... Less-educated patients and patients who had used narcotic painkillers ... said study lead author Dr. Brent Morris, a shoulder and ... suggests that doctors aren,t talking to one another about the ...
    (Date:8/30/2014)... 30, 2014 "My wife suffered neck, ... car accident," said one of two inventors from Bethel, ... her shoulder and neck area. She tried other pillows ... and pressure, assisting in comfort and providing extra sleep." ... CRADLE to support the head, neck and back comfortably. ...
    (Date:8/30/2014)... August 30, 2014 "My niece developed ... that, at any moment, her fever might get worse," ... keep me well aware of how she was doing, ... TEMP ALARM to continuously monitor a child's temperature. The ... fever. This ensures that prompt medical care can be ...
    Breaking Medicine News(10 mins):Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3
    ... , , , ... (Hologic or the Company) (Nasdaq: HOLX ), a ... systems and surgical products dedicated to serving the healthcare needs ... (FDA) cleared the Company,s 510K application for the MammoSite((R)) ML ...
    ... , NEW YORK, Sept. 5 Reporter Jim ... 5, 2009) Mr. Rutenberg accused me of making false statements, but ... statements are true. Mr. Rutenberg is the one writing falsehoods. ... are not what,s needed. The focus should be on the health ...
    ... ... of Hissey Kientz, LLP is warning consumers to immediately stop ... prior to a colonoscopy. In December 2008 the Food and Drug Administration ... the FDA’s warnings about the dangers of Phospho-soda and Fleet’s recall of ...
    ... ... winners of the 2009 research grants. This year,s grantees will explore such important ... opioids enhance migraine pain. , ... (PRWEB) September 5, 2009 -- The Migraine Research Foundation (MRF), the only ...
    ... WASHINGTON, Sept. 4 The California Nurses ... of Medicine for recommending strong patient safety protections for ... ongoing H1N1/swine flu pandemic--and calls on the Centers for ... , "America,s registered nurses have significant ...
    ... dual parents for child,s success , SATURDAY, Sept. 5 (HealthDay ... one- or two-parent household -- may help a child succeed ... findings, by an Ohio State University professor, challenge the conventional ... single parent marrying or moving in with a partner may ...
    Cached Medicine News:Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 2Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 3Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 4Health News:Betsy McCaughey Addresses New York Times: Charges of Falsehoods But No Evidence 2Health News:Betsy McCaughey Addresses New York Times: Charges of Falsehoods But No Evidence 3Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 2Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 3Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 4Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 2Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 3Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 4Health News:America's Registered Nurses Applaud New Institute of Medicine H1N1/Swine Flu Safety Recommendations -- and Call on CDC to Maintain Stringent Safety Guidelines 2Health News:Single Parents May Do as Well as Two: Study 2
    1000 L, Racked, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
    300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
    Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
    ... Eliminate aerosol contamination, which ... in PCR. Hydrophobic, nonwicking ... air can pass through ... in contrast to tips ...
    Medicine Products: